Abstract
This study evaluated the necessity of Western blotting (WB) in samples with inconsistent results in detecting anti-treponema pallidum (TP) antibodies by enzyme-linked immunosorbent assay (ELISA) and Treponema pallidum granule agglutination assay (TPPA). A retrospective analysis of 106,757 specimens was conducted. Results showed that while TPPA is an effective retest method, WB is necessary for final confirmation when results are inconsistent, resolving diagnostic uncertainty and preventing misdiagnosis.
Introduction
Syphilis diagnosis relies heavily on serological tests that detect antibodies against Treponema pallidum (TP). Most laboratories use a two-step "reverse" algorithm: first, a highly sensitive screening test like ELISA (Enzyme-Linked Immunosorbent Assay), followed by a highly specific confirmatory test like TPPA (TP Particle Agglutination Assay). However, these tests don't always agree. ELISA can produce false positives due to cross-reactivity, while TPPA can yield false negatives due to antigen selection or subjective interpretation. This paper evaluates whether Western Blotting—a technique that identifies antibodies against specific bacterial proteins—can effectively resolve these inconsistencies.
Methods
The researchers conducted a retrospective analysis of 106,757 anti-TP specimens collected at The Second Hospital of Jiaxing between August 2018 and December 2019.
- Screening: All samples underwent ELISA.
- Retesting: Samples that were ELISA-positive (S/CO ≥ 1) or ELISA-negative but showed visible color on the plate (suggesting a weak reaction) were retested with TPPA.
- Confirmation: For the 163 samples where ELISA and TPPA results were inconsistent, Western Blotting (WB) for both IgG and IgM antibodies was used as the final arbiter.
- Statistical Analysis: Chi-square tests were used to determine if the differences between the testing methods were statistically significant.
Key Results
Out of the 106,757 specimens screened, 3,972 were retested by TPPA. The majority (3,809) were positive by both methods. However, 163 specimens showed inconsistent results between ELISA and TPPA, which were then subjected to WB confirmation.
Out of the 163 inconsistent samples, WB confirmed 31 Positive (19.02%), 93 Negative (57.06%), and 39 Suspicious (23.93%). The differences between ELISA/TPPA results and WB results were statistically significant ($P < 0.05$), proving that neither ELISA nor TPPA alone is sufficient when results conflict.
Key Insights and Ideas
- The "Invisible" Positive: The authors identified 29 samples that were technically ELISA-negative (S/CO < 1) but showed visible chromogeny (color) on the test plate. WB confirmed that nearly 45% of these were actually positive, suggesting that numerical cut-offs can miss early infections.
- TPPA is Not Infallible: While often treated as a gold standard, TPPA missed 13 cases that were confirmed positive by WB.
- Resolving the Gray Zone: The study investigated how WB results correlate with ELISA S/CO values in inconsistent cases, particularly for those that were ELISA-positive but TPPA-negative or reserve.
- Biological Interference: Many "suspicious" results were linked to elevated ferritin or tumor markers, suggesting non-specific immune responses can interfere with syphilis serology.
- The "Suspicious" WB Result: Most suspicious WB results eventually turned positive in follow-ups, indicating they often represent very early stages of infection.
Limitations and Future Work
A significant portion of samples (24% of the inconsistent group) remained "suspicious" even after Western Blotting, posing a challenge for immediate clinical decision-making. Future research is needed to understand the exact biochemical mechanisms of interference from markers like ferritin and to obtain more comprehensive follow-up data for "suspicious" cases.
Conclusions
TPPA is an effective retest method for anti-TP antibody detection. However, if ELISA and TPPA results are inconsistent, WB is necessary for confirmation to ensure diagnostic accuracy and prevent both misdiagnosis and missed infections.
Summary updated